In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.
about
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatIdentification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniaeMolecular basis of bacterial outer membrane permeability revisitedModulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans ModelContribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniaeA novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniaeOuter membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains.Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon.Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes.Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniaeCharacterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance.Cloning, sequencing, and role in serum susceptibility of porin II from mesophilic Aeromonas hydrophila.Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in PolandIdentification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae.Down-regulation of porin M35 in Moraxella catarrhalis by aminopenicillins and environmental factors and its potential contribution to the mechanism of resistance to aminopenicillinsCephamycin resistance in clinical isolates and laboratory-derived strains of Escherichia coli, Nova Scotia, Canada.Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.Extended-spectrum beta-lactamases in Ireland, including a novel enzyme, TEM-102.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Recent developments in beta lactamases and extended spectrum beta lactamases.Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore.Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance.Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.Triton Hodge Test: Improved Protocol for Modified Hodge Test for Enhanced Detection of NDM and Other Carbapenemase Producers.Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitalsAmpC beta-lactamases.Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.β-Lactams and β-Lactamase Inhibitors: An Overview.High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.
P2860
Q24550671-06EEC5FF-A6D8-4679-95A4-B290B1F0B204Q28546573-52EEA9E5-66F4-41FF-A188-D1B6133AACA5Q29616208-A9DDDF21-29E4-46D4-8CEA-CB35DE62A3C5Q30385057-B50F54FC-6369-475E-8838-35BE3DD62774Q33474709-111F7C33-C845-4431-B874-33141FE961BCQ33690561-F843AD57-47B2-47AA-87A7-D45AD6DC99A5Q33694016-47341B7D-6C9C-450C-BE41-7D3197F2AF5CQ33694558-97261D15-F958-4675-B7AD-25DCEDA11753Q33885250-162D112E-D714-430B-9F6F-93D123929FEDQ33973139-979BBF9E-F5C4-49A5-AABF-30A9F9762BFCQ33976721-CC4FFD9F-E3ED-476D-ADAB-9CD1A90BA038Q33977146-08166F47-1D21-4157-B3CE-FC6116773858Q33980456-057A65F3-CE91-43F5-B459-4BA4EB5C5AF5Q33991864-542D3B5E-1A99-4DC3-9A54-4FB1CED9DCB7Q34003795-EE2926D0-1A30-4FAB-B168-9A8EF11215F4Q34104447-F9082273-79B6-4B49-8F78-90623976BC78Q34112401-54054CC3-8FB8-4F56-94FA-5AAC72D9C898Q34138479-34B4EB16-125C-4B90-A7F0-8E8720B6CAA6Q34548992-1838ABD3-5644-4915-803F-C3FC9916939BQ34737663-11B3ABB2-BB69-46B3-BA9F-723C74D82464Q34991064-D6DAA24E-6F43-488E-99DB-BFDBD18CDC46Q35023326-414F2574-3C5F-4D4B-8D07-9C05D200ECC1Q35133558-9E06B51B-8FF5-4366-9E3F-64023AE167BDQ35135773-67CDABFC-3F82-430A-8921-DFD8A3B7EA11Q35166203-0A6E177B-3997-4735-A281-E53BABF16935Q35482558-EF04D124-22EE-4C03-8CB8-0C1935448CF7Q35590126-A66008FA-EF88-4AD7-A2A4-C401F7274383Q35685143-5FF5A0C9-41D8-44FA-AA09-CA66FDBF3287Q36047378-60FFAEA8-AA01-4017-AE72-31B138E60C24Q36530330-5C155BB4-02E8-4A7C-AD9A-36FB3599CB3FQ36620830-421134B0-1E21-4898-8CD8-5EAFE99D8903Q37119956-E4182DBB-7FC7-40CD-B7D5-C65F7306639FQ37366249-873C3178-6691-45E3-BF77-9C0A6B125342Q37409385-8AD8C88C-F30F-4ECD-BDAC-0845B82F8106Q38471723-DDCFD04B-DAE9-448B-A440-52132308A709Q38626877-97AE715C-6A00-4A8D-BD9D-5411D87C9A00Q38872374-50F4CE74-A1D1-41C2-A169-02C575F04E12Q39472821-37C00CF9-F00A-4097-AE4E-7A6EE7EA80B5Q39643233-E0D4967C-434A-4080-8F24-A062D74FF1E1Q39657843-2FCBE3E2-3DC4-4847-B1E5-30340DD29639
P2860
In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
In vivo selection of porin-def ...... anded-spectrum-cephalosporins.
@ast
In vivo selection of porin-def ...... anded-spectrum-cephalosporins.
@en
type
label
In vivo selection of porin-def ...... anded-spectrum-cephalosporins.
@ast
In vivo selection of porin-def ...... anded-spectrum-cephalosporins.
@en
prefLabel
In vivo selection of porin-def ...... anded-spectrum-cephalosporins.
@ast
In vivo selection of porin-def ...... anded-spectrum-cephalosporins.
@en
P2093
P2860
P356
P1476
In vivo selection of porin-def ...... panded-spectrum-cephalosporins
@en
P2093
Hernández-Allés S
Martínez-Martínez L
P2860
P304
P356
10.1128/AAC.40.2.342
P407
P577
1996-02-01T00:00:00Z